Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Pfizer joins Milner Therapeutics Consortium to support Cambridge research

Pfizer joins Milner Therapeutics Consortium to support Cambridge research

24th January 2017

Pfizer has announced a new partnership with the Milner Therapeutics Institute that will see the company become part of the Milner Therapeutics Consortium.

The consortium was established in 2015 to act as a matchmaking service between pharmaceutical companies and researchers in Cambridge, facilitating the efficient transfer of materials between industry and academia, and the allocation of funds for partnering opportunities.

Company partners are able to work individually with academics or through joint activities to help accelerate their drug development activities, with an innovation board responsible for overseeing strategic direction, collective research funding and collaborative activities.

Dr Ron Newbold, vice-president for external research and development innovation at Pfizer, will join the Milner innovation board following this announcement, taking his place alongside representatives from Astex, AstraZeneca, GlaxoSmithKline, Shionogi, MedImmune, the University of Cambridge, the Babraham Institute and the Sanger Institute.

He said: "The UK has a very strong academic and biotech community, and we anticipate working with many world-class scientists that will be supported and inspired by the work of the Milner Institute in the coming years."

With over 20 years of experience within the pharmaceutical market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current pharmaceutical roles we have available, you can search for the latest job roles, register your details, or contact the team today.ADNFCR-8000103-ID-801831441-ADNFCR

We currently have 10 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.